Virtus ETF Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,870
| Closed | -$203K | – | 343 |
|
|
2025
Q1 | $203K | Sell |
2,870
-2,407
| -46% | -$170K | 0.26% | 93 |
|
|
2024
Q4 | $347K | Buy |
5,277
+1,367
| +35% | +$89.9K | 0.14% | 202 |
|
|
2024
Q3 | $275K | Hold |
3,910
| – | – | 0.13% | 236 |
|
|
2024
Q2 | $322K | Buy |
3,910
+6
| +0.2% | +$494 | 0.16% | 218 |
|
|
2024
Q1 | $341K | Buy |
3,904
+562
| +17% | +$49.1K | 0.18% | 215 |
|
|
2023
Q4 | $322K | Buy |
3,342
+121
| +4% | +$11.7K | 0.2% | 215 |
|
|
2023
Q3 | $285K | Sell |
3,221
-419
| -12% | -$37.1K | 0.17% | 206 |
|
|
2023
Q2 | $316K | Buy |
3,640
+801
| +28% | +$69.4K | 0.19% | 191 |
|
|
2023
Q1 | $276K | Buy |
2,839
+47
| +2% | +$4.57K | 0.15% | 261 |
|
|
2022
Q4 | $289K | Sell |
2,792
-502
| -15% | -$52K | 0.15% | 288 |
|
|
2022
Q3 | $279K | Buy |
3,294
+48
| +1% | +$4.07K | 0.11% | 281 |
|
|
2022
Q2 | $269K | Sell |
3,246
-1,240
| -28% | -$103K | 0.1% | 282 |
|
|
2022
Q1 | $346K | Hold |
4,486
| – | – | 0.15% | 160 |
|
|
2021
Q4 | $396K | Sell |
4,486
-1,058
| -19% | -$93.4K | 0.15% | 154 |
|
|
2021
Q3 | $428K | Sell |
5,544
-510
| -8% | -$39.4K | 0.19% | 162 |
|
|
2021
Q2 | $505K | Sell |
6,054
-1,496
| -20% | -$125K | 0.21% | 146 |
|
|
2021
Q1 | $570K | Buy |
7,550
+204
| +3% | +$15.4K | 0.24% | 135 |
|
|
2020
Q4 | $644K | Buy |
7,346
+1,817
| +33% | +$159K | 0.27% | 97 |
|
|
2020
Q3 | $421K | Buy |
5,529
+466
| +9% | +$35.5K | 0.22% | 158 |
|
|
2020
Q2 | $624K | Sell |
5,063
-2,274
| -31% | -$280K | 0.3% | 107 |
|
|
2020
Q1 | $620K | Sell |
7,337
-619
| -8% | -$52.3K | 0.26% | 148 |
|
|
2019
Q4 | $673K | Sell |
7,956
-610
| -7% | -$51.6K | 0.11% | 159 |
|
|
2019
Q3 | $577K | Sell |
8,566
-1,447
| -14% | -$97.5K | 0.12% | 176 |
|
|
2019
Q2 | $858K | Buy |
10,013
+1,728
| +21% | +$148K | 0.18% | 166 |
|
|
2019
Q1 | $736K | Buy |
8,285
+1,832
| +28% | +$163K | 1.57% | 19 |
|
|
2018
Q4 | $549K | Sell |
6,453
-2,247
| -26% | -$191K | 0.09% | 68 |
|
|
2018
Q3 | $844K | Buy |
8,700
+586
| +7% | +$56.8K | 0.09% | 61 |
|
|
2018
Q2 | $764K | Sell |
8,114
-2,197
| -21% | -$207K | 0.68% | 55 |
|
|
2018
Q1 | $836K | Sell |
10,311
-599
| -5% | -$48.6K | 0.73% | 67 |
|
|
2017
Q4 | $973K | Sell |
10,910
-350
| -3% | -$31.2K | 1.22% | 27 |
|
|
2017
Q3 | $1.05M | Hold |
11,260
| – | – | 0.14% | 56 |
|
|
2017
Q2 | $1.02M | Sell |
11,260
-838
| -7% | -$76.1K | 0.15% | 64 |
|
|
2017
Q1 | $1.06M | Buy |
12,098
+1,163
| +11% | +$102K | 0.19% | 61 |
|
|
2016
Q4 | $906K | Buy |
10,935
+3,254
| +42% | +$270K | 0.27% | 68 |
|
|
2016
Q3 | $711K | Buy |
7,681
+968
| +14% | +$89.6K | 0.34% | 49 |
|
|
2016
Q2 | $522K | Buy |
6,713
+811
| +14% | +$63.1K | 0.39% | 50 |
|
|
2016
Q1 | $487K | Buy |
+5,902
| New | +$487K | 0.67% | 39 |
|